Newsroom
EndoTool Subcutaneous Inpatient Insulin Dosing Solution Simplifies Provider Workflow While Improving Patient Safety
Monarch Medical Technologies Achieves ISO 13485 Certification
Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, has earned ISO 13485:2016 certification for its quality management system from the independent certifying body, TÜV SÜD
Monarch Medical Technologies Chief Clinical Officer is Speaker at American Diabetes Care and Education Specialists Annual Virtual Conference
Session Encourages Diabetes Clinicians to Gain Data Visualization Skills
Mercyhealth Partners with Monarch Medical Technologies to Optimize Inpatient Diabetes Management
Mercyhealth, a multi-regional healthcare system serving northern Illinois and southern Wisconsin, partners with Monarch Medical Technologies to improve care for patients with diabetes.
Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management
Monarch Medical Technologies and Voluntis to Host June 25th Webinar to Discuss Best Practices for Initiating and Managing Insulin Therapy Across the Continuum of Care.
Monarch Medical Technologies Announces New Insulin-on-Board Adjustment for Subcutaneous Insulin Dosing
Monarch’s EndoTool® SubQ to feature optional insulin-on-board (IOB) calculation for subcutaneous insulin to mitigate the risk of hypoglycemia.
Monarch Medical Technologies to Participate in the American Diabetes Association’s 79th Scientific Sessions and DiabetesMine D-Data ExChange
Monarch will be participating in the DiabetesMine D-Data ExChange on June 7th, 2019 and the American Diabetes Association’s 79th Scientific Sessions on June 7-11, 2019 in San Francisco, CA.